Prospera Financial Services Portfolio holdings
Prospera Financial Services has been in business since 1982 and works as both an investment adviser and a brokerage. Prospera Financial, LLC owns it outright, and is itself majority owned and run, indirectly, by co-chief executives David Stringer and Tim Edwards and secretary Richard Pascuzzi. Its advisers offer clients its own Summit advisory programs and financial planning, plus programs from Envestnet, SEI and AssetMark, and most can also advise on insurance through its affiliate Prospera Life & Annuity.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$48.3M |
| 2 |
SpaceX
SPCX
|
+$43.1M |
| 3 |
Apple
AAPL
|
+$42.8M |
| 4 |
Listed Funds Trust Roundhill Magnificent Seven ETF
MAGS
|
+$32.5M |
| 5 |
Cisco
CSCO
|
+$24.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Value ETF
IWD
|
+$36.9M |
| 2 |
Arm
ARM
|
+$25.2M |
| 3 |
AbbVie
ABBV
|
+$24.2M |
| 4 |
Western Digital
WDC
|
+$23.2M |
| 5 |
Intel
INTC
|
+$16.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.65% |
| 2 | Technology | 20.94% |
| 3 | Financials | 7.06% |
| 4 | Industrials | 6.96% |
| 5 | Healthcare | 5.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1301
Cullen/Frost Bankers
CFR
$9.7B
| $272K | ﹤0.01% |
1,727
-62
| -3% | -$10K |
2024 Q3
8 quarters
|
|
1302
Invesco S&P 500 Equal Weight Health Care ETF
RSPH
$1.01B
| $272K | ﹤0.01% |
+6,843
| New | +$245K |
2026 Q3
0 quarters
|
|
1303
Septerna Inc
SEPN
$2.28B
| $272K | ﹤0.01% |
+6,171
| New | +$234K |
2026 Q3
0 quarters
|
|
1304
Invesco Dow Jones Industrial Average Dividend ETF
DJD
$529M
| $271K | ﹤0.01% |
4,001
+9
| +0.2% | +$584 |
2025 Q2
5 quarters
|
|
1305
Western Copper and Gold
WRN
$337M
| $271K | ﹤0.01% |
171,500
+6,750
| +4% | +$15.6K |
2024 Q1
10 quarters
|
|
1306
General Mills
GIS
$19B
| $271K | ﹤0.01% |
7,888
+944
| +14% | +$35.2K |
2019 Q2
29 quarters
|
|
1307
iShares North American Natural Resources ETF
IGE
$776M
| $270K | ﹤0.01% |
4,057
-208
| -5% | -$12.9K |
2025 Q3
4 quarters
|
|
1308
Viking Therapeutics
VKTX
$3.42B
| $268K | ﹤0.01% |
9,842
+61
| +0.6% | +$2.11K |
2025 Q3
4 quarters
|
|
1309
Edwards Lifesciences
EW
$58.7B
| $268K | ﹤0.01% |
2,912
-89
| -3% | -$7.91K |
2025 Q4
3 quarters
|
|
1310
iShares iBonds Dec 2027 Term Treasury ETF
IBTH
$2.42B
| $267K | ﹤0.01% |
11,964
-1,626
| -12% | -$36.3K |
2026 Q1
2 quarters
|
|
1311
FT Vest US Equity Deep Buffer ETF September
DSEP
$423M
| $267K | ﹤0.01% |
5,486
-21,703
| -80% | -$1.05M |
2022 Q3
16 quarters
|
|
1312
iShares Emerging Markets Dividend ETF
DVYE
$1.11B
| $267K | ﹤0.01% |
7,998
-122
| -2% | -$4.19K |
2025 Q4
3 quarters
|
|
1313
First Trust Dow 30 Equal Weight ETF
EDOW
$321M
| $266K | ﹤0.01% |
+5,783
| New | +$263K |
2026 Q3
0 quarters
|
|
1314
Ziff Davis
ZD
$1.7B
| $266K | ﹤0.01% |
+4,859
| New | +$266K |
2026 Q3
0 quarters
|
|
1315
Calamos Strategic Total Return Fund
CSQ
$3.06B
| $266K | ﹤0.01% |
13,583
+1,222
| +10% | +$25.2K |
2026 Q1
2 quarters
|
|
1316
Peoples Bancorp
PEBO
$1.39B
| $266K | ﹤0.01% |
+6,888
| New | +$274K |
2026 Q3
0 quarters
|
|
1317
iShares ESG Aware MSCI EAFE ETF
ESGD
$11.6B
| $265K | ﹤0.01% |
2,578
-103
| -4% | -$10.8K |
2025 Q4
3 quarters
|
|
1318
Uranium Energy
UEC
$3.43B
| $264K | ﹤0.01% |
34,261
+1,620
| +5% | +$17.2K |
2024 Q4
7 quarters
|
|
1319
T. Rowe Price QM US Bond ETF
TAGG
$2.78B
| $263K | ﹤0.01% |
+6,387
| New | +$267K |
2026 Q3
0 quarters
|
|
1320
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$10.8B
| $263K | ﹤0.01% |
1,774
+416
| +31% | +$65K |
2025 Q4
3 quarters
|
|
1321
HF Sinclair
DINO
$16.4B
| $263K | ﹤0.01% |
+2,286
| New | +$216K |
2026 Q3
0 quarters
|
|
1322
Vanguard Long-Term Bond ETF
BLV
$5.55B
| $263K | ﹤0.01% |
+4,026
| New | +$266K |
2026 Q3
0 quarters
|
|
1323
United Bankshares
UBSI
$6.57B
| $262K | ﹤0.01% |
5,443
| – | – |
2020 Q4
23 quarters
|
|
1324
Darden Restaurants
DRI
$25.6B
| $261K | ﹤0.01% |
+1,184
| New | +$247K |
2026 Q3
0 quarters
|
|
1325
Sea Limited
SE
$46.4B
| $260K | ﹤0.01% |
+3,508
| New | +$385K |
2026 Q3
0 quarters
|
|
Similar funds
Prospera Financial Services's Q3 2026 Portfolio in Review
As of Q3 2026, Prospera Financial Services held 1,651 positions worth $7.73B, up 12% from $6.89B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Prospera Financial Services deployed $900M of net new capital in Q3 2026, opening 183 new positions and adding to 799 existing holdings. Its largest new stake was iShares US Pharmaceuticals ETF: 130,953 shares worth $14.1M.
By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, down from 43% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares Russell 1000 Value ETF, an estimated $36.9M trimmed.
- Prospera Financial Services's largest Q3 2026 buy was iShares US Pharmaceuticals ETF: 130,953 shares worth $14.1M.
- Prospera Financial Services added most to NVIDIA in Q3 2026, an estimated $48.3M increase.
- Prospera Financial Services's biggest Q3 2026 reduction was iShares Russell 1000 Value ETF, cutting an estimated $36.9M.
- Prospera Financial Services fully exited AbbVie in Q3 2026, selling an estimated $24.2M.
- Prospera Financial Services's ten largest holdings make up 19% of its $7.73B portfolio in Q3 2026.
- Prospera Financial Services opened 183 new positions and closed 140 in Q3 2026.
- Prospera Financial Services's portfolio value rose 12% quarter-over-quarter to $7.73B.
Based on Prospera Financial Services's 13F filing for Q3 2026, filed 4 Nov 2026.